{"version":"1.0","type":"link","title":"Evaluation of Pathological Complete Response Rate in Patients with HER2-Positive Breast Cancer Undergoing Neoadjuvant Trastuzumab and Chemotherapy With or Without Anthracycline.","author_name":"Rocha IM 외","author_url":"https://prs-insight.online/author/Rocha%20IM","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/91163","thumbnail_width":1200,"thumbnail_height":630}